A detailed history of Plato Investment Management LTD transactions in Merck & Co., Inc. stock. As of the latest transaction made, Plato Investment Management LTD holds 50,624 shares of MRK stock, worth $4.99 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares
50,624
Previous 50,167 0.91%
Holding current value
$4.99 Million
Previous $6.21 Billion 7.53%
% of portfolio
0.47%
Previous 0.58%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$111.15 - $128.97 $50,795 - $58,939
457 Added 0.91%
50,624 $5.74 Billion
Q2 2024

Aug 08, 2024

BUY
$123.8 - $132.96 $348,001 - $373,750
2,811 Added 5.94%
50,167 $6.21 Billion
Q1 2024

May 14, 2024

BUY
$113.24 - $131.95 $4.61 Million - $5.37 Million
40,734 Added 615.13%
47,356 $9.58 Billion
Q4 2023

Feb 12, 2024

BUY
$100.18 - $109.02 $663,391 - $721,930
6,622 New
6,622 $722 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $250B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Plato Investment Management LTD Portfolio

Follow Plato Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Plato Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Plato Investment Management LTD with notifications on news.